Genotype distribution of human papillomavirus (HPV) and co-infections in cervical cytologic specimens from two outpatient gynecological clinics in a region of southeast Spain

BMC Infectious Diseases

Volumn 9, Issue , 2009, Pages

  Conesa Zamora, Pablo ^a   Ortiz Reina, Sebastián ^a   Moya Biosca, Joaquín ^a   Doménech Peris, Asunción ^a   Orantes Casado, Francisco ^a   Pérez Guillermo, Miguel ^a   Egea Cortines, Marcos ^b  

^a Hospital Universitario Santa Maria del Rosell   (Spain)

^b TECHNICAL UNIVERSITY OF CARTAGENA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CELL HYBRIDIZATION; CONTROLLED STUDY; CYTOPATHOLOGY; FEMALE; GENOTYPE; GYNECOLOGIC CARE; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 6; MAJOR CLINICAL STUDY; MIXED INFECTION; PHYLOGENY; POLYMERASE CHAIN REACTION; SPAIN; SQUAMOUS CELL; UTERINE CERVIX CYTOLOGY; VACCINATION; VERRUCA VULGARIS; GENETICS; PAPILLOMA VIRUS; PREVALENCE; VAGINA SMEAR; VIROLOGY; VIRUS INFECTION;

VIRUS DNA;

DNA, VIRAL; FEMALE; GENOTYPE; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; SPAIN; VAGINAL SMEARS;

EID: 69549130864     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-9-124     Document Type: Article

References (37)

1. Zur Hausen H Oncogenic DNA viruses Oncogene 2001, 20(54):7820-7823 10.1038/sj.onc.1204958 11753664
2. de Villiers EM Fauquet C Broker TR Bernard HU zur Hausen H Classification of papillomaviruses Virology 2004, 324(1):17-27 10.1016/ j.virol.2004.03.033 15183049
3. Bernard HU The clinical importance of the nomenclature, evolution and taxonomy of human papillomaviruses Journal of Clinical Virology 2005, 32:S1-S6 10.1016/j.jcv.2004.10.021 15753006
4. zur Hausen H Papillomaviruses and cancer: From basic studies to clinical application Nature Reviews Cancer 2002, 2(5):342-350 10.1038/nrc798 12044010
5. Munoz N Bosch FX Castellsague X Diaz M De Sanjose S Hammouda D Shah KV Meijer CJLM Against which human papillomavirus types shall we vaccinate and screen? The international perspective International Journal of Cancer 2004, 111(2):278-285 10.1002/ijc.20244
6. Eiben GL Da Silva DM Fausch SC Le Poole IC Nishimura MI Kast WM Cervical cancer vaccines: Recent advances in HPV research Viral Immunology 2003, 16(2):111-121 10.1089/088282403322017866 12828864
7. Gonzalez-Bosquet E Esteva C Munoz-Almagro C Ferrer P Perez M Lailla JM Identification of vaccine human papillomavirus genotypes in squamous intraepithelial lesions (CIN2-3) Gynecologic Oncology 2008, 111(1):9-12 10.1016/j.ygyno.2008.06.012 18684497
8. Rousseau MC Villa LL Costa MC Abrahamowicz M Rohan TE Franco E Occurrence of cervical infection with multiple human papillomavirus types is associated with age and cytologic abnormalities Sexually Transmitted Diseases 2003, 30(7):581-587 10.1097/ 00007435-200307000-00010 12838088
9. Rousseau MC Pereira JS Prado JCM Villa LL Rohan TE Franco EL Cervical coinfection with human papillomavirus (HPV) types as a predictor of acquisition and persistence of HPV infection Journal of Infectious Diseases 2001, 184(12):1508-1517 10.1086/324579 11740725
10. Mendez F Munoz N Posso H Molano M Moreno V Brule van den AJC Ronderos M Meijer C Munoz A Papillomaviru INCH et al Cervical coinfection with human papillomavirus (HPV) types and possible implications for the prevention of cervical cancer by HPV vaccines Journal of Infectious Diseases 2005, 192(7):1158-1165 10.1086/444391 16136457
11. Thomas KK Hughes JP Kuypers JM Kiviat NB Lee SK Adam DE Koutsky LA Concurrent and sequential acquisition of different genital human papillomavirus types J Infect Dis 2000, 182(4):1097-1102 10.1086/315805 10979905
12. Paavonen J Jenkins D Bosch FX Naud P Salmeron J Wheeler CM Chow SN Apter DL Kitchener HC Castellsague X et al Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: An interim analysis of a phase III double-blind, randomised controlled trial Lancet 2007, 369(9580):2161-2170 10.1016/S0140-6736(07)60946-5 17602732
13. Villa LL Costa RLR Petta CA Andrade RP Paavonen J Iversen OE Olsson SE Hoye J Steinwall M Riis-Johannessen G et al High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up British Journal of Cancer 2006, 95(11):1459-1466 10.1038/sj.bjc.6603469 17117182
14. Woodman CBJ Collins SI Young LS The natural history of cervical HPV infection: Unresolved issues Nature Reviews Cancer 2007, 7(1):11-22 10.1038/nrc2050 17186016
15. Arias-Pulido H Peyton CL Torrez-Martinez N Anderson DN Wheeler CM Human papillomavirus type 18 variant lineages in United States populations characterized by sequence analysis of LCR-E6, E2, and L1 regions Virology 2005, 338(1):22-34 10.1016/j.virol.2005.04.022 15936050
16. Calleja-Macias IE Villa LL Prado JC Kalantari M Allan B Williamson AL Chung LP Collins RJ Zuna RE Dunn ST et al Worldwide genomic diversity of the high-risk human papillomavirus types 31, 35, 52, and 58, four close relatives of human papillomavirus type 16 Journal of Virology 2005, 79(21):13630-13640 1262609 16227283 10.1128/JVI.79.21.13630-13640.2005
17. Prado JC Calleja-Macias IE Bernard HU Kalantari M Macay SA Allan B Williamson AL Chung LP Collins RJ Zuna RE Worldwide genomic diversity of the human papillomaviruses-53, 56, and 66, a group of high-risk HPVs unrelated to HPV-16 and HPV-18 Virology 2005, 340(1):95-104 10.1016/ j.virol.2005.06.024 16039686
18. Calleja-Macias IE Kalantari M Huh J Ortiz-Lopez R Rojas-Martinez A Gonzalez-Guerrero JF Williamson AL Hagmar B Wiley DJ Villarreal L et al Genomic diversity of human papillomavirus-16, 18, 31, and 35 isolates in a Mexican population and relationship to European, African, and Native American variants Virology 2004, 319(2):315-323 10.1016/ j.virol.2003.11.009 14980491
19. Smith JF Brownlow M Brown M Kowalski R Esser MT Ruiz W Barr E Brown DR Bryan JT Antibodies from women immunized with Gardasil cross-neutralize HPV 45 pseudovirions Hum Vaccin 2007, 3(4):109-115 17611417
20. Slupetzky K Gambhira R Culp TD Shafti-Keramat S Schellenbacher C Christensen ND Roden RBS Kirnbauer R A papillomavirus-like particle (VLP) vaccine displaying HPV16 L2 epitopes induces cross-neutralizing antibodies to HPV11 Vaccine 2007, 25(11):2001-2010 10.1016/ j.vaccine.2006.11.049 17239496
21. Harper DM Franco EL Wheeler CM Moscicki AB Romanowski B Roteli-Martins CM Jenkins D Schuind A Costa Clemens SA Dubin G Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: Follow-up from a randomised control trial Lancet 2006, 367(9518):1247-1255 10.1016/S0140-6736(06)68439-0 16631880
22. Alameda F Bellosillo B Fuste P Musset M Marinoso ML Mancebo G Lopez-Yarto MT Carreras R Serrano S Human papillomavirus detection in urine samples: An alternative screening method J Low Genit Tract Dis 2007, 11(1):5-7 10.1097/01.lgt.0000230204.65742.e4 17194943
23. Conesa-Zamora P Domenech-Peris A Ortiz-Reina S Orantes-Casado FJ Acosta-Ortega J Garcia-Solano J Perez-Guillermo M Immunohistochemical evaluation of ProEx C in human papillomavirus-induced lesions of the cervix J Clin Pathol 2009, 62(2):159-62 10.1136/jcp.2008.061408 18930984
24. Gomez-Roman JJ Echevarria C Salas S Gonzalez-Moran MA Perez-Mies B Garcia-Higuera I Nicolas Martinez M Val-Bernal JF A type-specific study of human papillomavirus prevalence in cervicovaginal samples in three different Spanish regions Apmis 2009, 117(1):22-27 10.1111/ j.1600-0463.2008.00009.x 19161533
25. Munoz N Bosch FX de Sanjose S Herrero R Castellsague X Shah KV Snijders PJF Meijer CJLM Cerv IARCM Epidemiologic classification of human papillomavirus types associated with cervical cancer New England Journal of Medicine 2003, 348(6):518-527 10.1056/NEJMoa021641 12571259
26. Ortiz M Torres M Munoz L Fernandez-Garcia E Canals J Cabornero AI Aguilar E Ballesteros J del Amo J Garcia-Saiz A Oncogenic human papillomavirus (HPV) type distribution and HPV type 16 E6 variants in two Spanish population groups with different levels of HPV infection risk Journal of Clinical Microbiology 2006, 44(4):1428-1434 1448654 16597872 10.1128/JCM.44.4.1428-1434.2006
27. de Antonio JC Fernandez-Olmos A Mercadillo M Lindemann ML Mochales FB Detection of high-risk human papillomavirus by two molecular techniques: hybrid capture and linear array J Virol Methods 2008, 149(1):163-166 10.1016/j.jviromet.2008.01.021 18328575
28. Clifford GM Gallus S Herrero R Munoz N Snijders PJF Vaccarella S Anh PTH Ferreccio C Hieu NT Matos E et al Worldwide distribution of human papillomavirus types in cytologically normal women in the international Agency for Research on Cancer HPV prevalence surveys: A pooled analysis Lancet 2005, 366(9490):991-998 10.1016/S0140-6736(05)67069-9 16168781
29. Ammatuna P Giovannelli L Matranga D Ciriminna S Perino A Prevalence of genital human papilloma virus infection and genotypes among young women in Sicily, South Italy Cancer Epidemiol Biomarkers Prev 2008, 17(8):2002-2006 10.1158/1055-9965.EPI-08-0180 18708390
30. Capra G Giovannelli L Bellavia C Mighore MC Caleca MP Perino A Ammatuna P HPV genotype prevalence in cytologically abnormal cervical samples from women living in south Italy Virus Research 2008, 133(2):195-200 10.1016/j.virusres.2007.12.020 18282628
31. Clifford GM Rana RK Franceschi S Smith JS Gough G Pimenta JM Human papillomavirus genotype distribution in low-grade cervical lesions: Comparison by geographic region and with cervical cancer Cancer Epidemiology Biomarkers & Prevention 2005, 14(5):1157-1164 10.1158/ 1055-9965.EPI-04-0812
32. Qu WM Jiang G Cruz Y Chang CJ Ho GYF Klein RS Burk RD PCR detection of human papillomavirus: Comparison between MY09/MY11 and GP5+/GP6+ primer systems Journal of Clinical Microbiology 1997, 35(6):1304-1310 229739 9163434
33. Poljak M Marin IJ Seme K Vince A Hybrid Capture IIHPV Test detects at least 15 human papillomavirus genotypes not included in its current high-risk probe cocktail Journal of Clinical Virology 2002, 25(25):S89-S97 10.1016/S1386-6532(02)00187-7 12467782
34. Pretet JL Jacquard AC Saunier M Clavel C Dachez R Gondry J Pradat P Soubeyrand B Leocmach Y Mougin C et al Human papillomavirus genotype distribution in low-grade squamous intraepithelial lesions in France and comparison with CIN2/3 and invasive cervical cancer: The EDiTH III study Gynecol Oncol 2008, 110(2):179-184 10.1016/j.ygyno.2008.04.012 18514800
35. Pannier-Stockman C Segard C Bennamar S Gondry J Boulanger JC Sevestre H Castelain S Duverlie G Prevalence of HPV genotypes determined by PCR and DNA sequencing in cervical specimens from French women with or without abnormalities Journal of Clinical Virology 2008, 42:353-360 10.1016/ j.jcv.2008.03.022 18485810
36. Pretet JL Jacquard AC Carcopino X Monnier-Benoit S Averous G Soubeyrand B Leocmach Y Mougin C Riethmuller D Human papillomavirus genotype distribution in high grade cervical lesions (CIN 2/3) in France: EDITH study Int J Cancer 2008, 122(2):424-427 10.1002/ijc.23093 17893883
37. Sasagawa T Basha W Yamazaki H Inoue M High-risk and multiple human papillomavirus infections associated with cervical abnormalities in Japanese women Cancer Epidemiology Biomarkers & Prevention 2001, 10(1):45-52